These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7097526)

  • 1. Use of dipole moment as a parameter in drug-receptor interaction and quantitative structure-activity relationship studies.
    Lien EJ; Guo ZR; Li RL; Su CT
    J Pharm Sci; 1982 Jun; 71(6):641-55. PubMed ID: 7097526
    [No Abstract]   [Full Text] [Related]  

  • 2. [Theoretical aspects of the quantitative study of the chemical structure-biological action relationship].
    Danchev D; Staneva D; Mikhaĭlova D; Nacheva R
    Eksp Med Morfol; 1979; 18(2):61-8. PubMed ID: 380967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Theoretical investigations of interactions between drugs and models of receptor sites, 3: induced fit interactions of verapamil derivatives].
    Höltje HD; Baranowski P
    Arch Pharm (Weinheim); 1983; 316(2):154-60. PubMed ID: 6847345
    [No Abstract]   [Full Text] [Related]  

  • 4. Recognition and activation mechanisms on the LSD/serotonin receptor: the molecular basis of structure activity relationships.
    Weinstein H; Green JP; Osman R; Edwards WD
    NIDA Res Monogr; 1978; (22):333-58. PubMed ID: 101884
    [No Abstract]   [Full Text] [Related]  

  • 5. Conformational study of lysergic acid derivatives in relation to their hallucinogenic and antiserotonin activities.
    Kumbar M
    NIDA Res Monogr; 1978; (22):374-407. PubMed ID: 101885
    [No Abstract]   [Full Text] [Related]  

  • 6. Aquatic invertebrates: model systems for study of receptor activation and evolution of receptor proteins.
    Lenhoff HM; Heagy W
    Annu Rev Pharmacol Toxicol; 1977; 17():243-58. PubMed ID: 17353
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative structure-activity relationship by distance geometry: quinazolines as dihydrofolate reductase inhibitors.
    Ghose AK; Crippen GM
    J Med Chem; 1982 Aug; 25(8):892-9. PubMed ID: 7120278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular requirements for recognition at glucoreceptor for insulin release.
    Weaver DC; Barry CD; McDaniel ML; Marshall GR; Lacy PE
    Mol Pharmacol; 1979 Sep; 16(2):361-8. PubMed ID: 390361
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary: The receptor concept in evolution.
    Ariëns EJ; Beld AJ
    Biochem Pharmacol; 1977 May; 26(10):913-8. PubMed ID: 324474
    [No Abstract]   [Full Text] [Related]  

  • 10. Structure and function of snake venom curarimimetic neurotoxins.
    Tsernoglou D; Petsko GA; Hudson RA
    Mol Pharmacol; 1978 Jul; 14(4):710-6. PubMed ID: 683181
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug interaction].
    Kukes VG; Rudakov AG
    Klin Med (Mosk); 1984 Jun; 62(6):9-16. PubMed ID: 6471806
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relation between the physical-chemical properties, the chemical reactivity and the local anesthetic action of 4-alkylbenzoic acid diethylamino ethyl ester (Paralkains). 30].
    Büchi J; Kestermann H; Perlia X
    Arzneimittelforschung; 1974 Apr; 24(4):485-93. PubMed ID: 4603792
    [No Abstract]   [Full Text] [Related]  

  • 13. [Estimation of the effects of cardenolides. 1. Relation between molecular physical parameters and parameters of action of cardenolides].
    Köpke K; Dittrich F; Berlin P
    Pharmazie; 1984 Mar; 39(3):173-6. PubMed ID: 6233620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structure-activity relationships of cyclic analogs of acetylcholine].
    Lambrecht G
    Pharmazie; 1976 Apr; 31(4):209-15. PubMed ID: 935221
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent physiochemical and quantum chemical studies on drugs of abuse and relevant biomolecules.
    Kaufman JJ
    NIDA Res Monogr; 1978; (22):250-77. PubMed ID: 30909
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between molecular orbital distributions in drug-receptor interaction: Diels-Alder reaction systems and dihydrofolate reductase system.
    Kubodera H; Umeyama H
    Chem Pharm Bull (Tokyo); 1987 Nov; 35(11):4377-94. PubMed ID: 3442879
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure-olfactory activity relationship in a group of substituted phenols.
    Kaliszan R; Pankowski M; Szymula L; Lamparczyk H; Nasal A; Tomaszewska B; Grzybowski J
    Pharmazie; 1982 Jul; 37(7):499-501. PubMed ID: 7134257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Practical problems of pharmacodynamics].
    Berkhin EB
    Klin Med (Mosk); 1986 Feb; 64(2):146-52. PubMed ID: 3702293
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular modeling in drug design.
    Marshall GR
    Psychopharmacol Ser; 1987; 3():3-11. PubMed ID: 3823093
    [No Abstract]   [Full Text] [Related]  

  • 20. Stereoselectivity and affinity in molecular pharmacology.
    Lehmann PA
    Prog Drug Res; 1976; 20():101-42. PubMed ID: 13457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.